Los Angeles Capital Management Portfolio holdings
AUM
$26.7B
1-Year Return
35.08%
This Quarter Return
+8.14%
1 Year Return
+35.08%
3 Year Return
+164.18%
5 Year Return
+293.76%
10 Year Return
+832%
AUM
$24.8B
AUM Growth
-$3.2B
(-11%)
Cap. Flow
-$4.66B
Cap. Flow
% of AUM
-18.83%
Top 10 Holdings %
Top 10 Hldgs %
35.3%
Holding
1,336
New
173
Increased
303
Reduced
574
Closed
184
Top Buys
| 1 |
Simon Property Group
SPG
|
+$168M |
| 2 |
Lockheed Martin
LMT
|
+$146M |
| 3 |
Philip Morris
PM
|
+$141M |
| 4 |
Equity Residential
EQR
|
+$136M |
| 5 |
US Bancorp
USB
|
+$129M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$588M |
| 2 |
Apple
AAPL
|
+$310M |
| 3 |
Microsoft
MSFT
|
+$303M |
| 4 |
Amazon
AMZN
|
+$302M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$234M |
Sector Composition
| 1 | Technology | 34.28% |
| 2 | Financials | 12.86% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Healthcare | 10.45% |
| 5 | Industrials | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Funko
FNKO
$182M
| $432K | ﹤0.01% |
35,317
-4,400
| -11% | -$53.8K |
|
902
Avantor
AVTR
$8.39B
| $431K | ﹤0.01% |
+16,645
| New | +$431K |
|
903
Evolent Health
EVH
$1.05B
| $430K | ﹤0.01% |
+15,191
| New | +$430K |
|
904
Skywest
SKYW
$4.35B
| $428K | ﹤0.01% |
5,035
-100
| -2% | -$8.5K |
|
905
Mesa Laboratories
MLAB
$339M
| $428K | ﹤0.01% |
3,294
-2,219
| -40% | -$288K |
|
906
ADT
ADT
$7.24B
| $426K | ﹤0.01% |
58,897
-7,733
| -12% | -$55.9K |
|
907
Yelp
YELP
$1.95B
| $425K | ﹤0.01% |
12,110
| – | – |
|
908
Interactive Brokers
IBKR
$28.4B
| $424K | ﹤0.01% |
12,164
+2,640
| +28% | +$92K |
|
909
Capital Bancorp
CBNK
$551M
| $422K | ﹤0.01% |
16,425
-2,100
| -11% | -$54K |
|
910
Fox Class A
FOXA
$28.5B
| $421K | ﹤0.01% |
9,948
-7,540
| -43% | -$319K |
|
911
Oshkosh
OSK
$8.77B
| $421K | ﹤0.01% |
4,200
-198,644
| -98% | -$19.9M |
|
912
Accuray
ARAY
$177M
| $418K | ﹤0.01% |
+232,218
| New | +$418K |
|
913
Thryv Holdings
THRY
$550M
| $417K | ﹤0.01% |
24,209
-3,100
| -11% | -$53.4K |
|
914
Taysha Gene Therapies
TSHA
$837M
| $416K | ﹤0.01% |
+206,992
| New | +$416K |
|
915
Royal Gold
RGLD
$12.5B
| $415K | ﹤0.01% |
2,961
+1,080
| +57% | +$152K |
|
916
Chord Energy
CHRD
$5.96B
| $410K | ﹤0.01% |
3,151
-22,067
| -88% | -$2.87M |
|
917
Altimmune
ALT
$321M
| $409K | ﹤0.01% |
66,537
-37,067
| -36% | -$228K |
|
918
Healthpeak Properties
DOC
$12.6B
| $407K | ﹤0.01% |
17,780
+769
| +5% | +$17.6K |
|
919
Capital City Bank Group
CCBG
$739M
| $406K | ﹤0.01% |
11,513
-1,400
| -11% | -$49.4K |
|
920
RAPT Therapeutics
RAPT
$268M
| $405K | ﹤0.01% |
25,180
+14,607
| +138% | +$235K |
|
921
Aviat Networks
AVNW
$305M
| $402K | ﹤0.01% |
18,594
-2,600
| -12% | -$56.2K |
|
922
Enhabit
EHAB
$399M
| $402K | ﹤0.01% |
50,883
+26,227
| +106% | +$207K |
|
923
United Bankshares
UBSI
$5.3B
| $401K | ﹤0.01% |
10,813
+2,051
| +23% | +$76.1K |
|
924
Editas Medicine
EDIT
$242M
| $401K | ﹤0.01% |
117,639
-13,310
| -10% | -$45.4K |
|
925
Becton Dickinson
BDX
$53.6B
| $401K | ﹤0.01% |
1,663
| – | – |
|